Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

Francesco Panza, Madia Lozupone, Vittorio Dibello, Antonio Greco, Antonio Daniele, Davide Seripa, Giancarlo Logroscino, Bruno P. Imbimbo

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)3-6
Number of pages4
JournalImmunotherapy
Volume11
Issue number1
DOIs
Publication statusPublished - Jan 1 2019

Keywords

  • aducanumab
  • Alzheimer's disease
  • BAN2401
  • dementia
  • MCI
  • monoclonal antibodies
  • passive immunotherapy
  • prodromal Alzheimer's disease

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this